Sutro Biopharma (STRO) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to -$13.3 million.
- Sutro Biopharma's Other Gross PP&E Adjustments rose 2988.38% to -$13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.3 million, marking a year-over-year increase of 2988.38%. This contributed to the annual value of $43.3 million for FY2024, which is 2142.68% up from last year.
- Sutro Biopharma's Other Gross PP&E Adjustments amounted to -$13.3 million in Q3 2025, which was up 2988.38% from -$14.8 million recorded in Q2 2025.
- Over the past 5 years, Sutro Biopharma's Other Gross PP&E Adjustments peaked at $43.3 million during Q4 2024, and registered a low of -$30.1 million during Q3 2021.
- For the 5-year period, Sutro Biopharma's Other Gross PP&E Adjustments averaged around -$9.4 million, with its median value being -$20.3 million (2024).
- Per our database at Business Quant, Sutro Biopharma's Other Gross PP&E Adjustments crashed by 5023.45% in 2021 and then soared by 3689.9% in 2022.
- Over the past 5 years, Sutro Biopharma's Other Gross PP&E Adjustments (Quarter) stood at $23.0 million in 2021, then soared by 36.9% to $31.5 million in 2022, then rose by 13.18% to $35.7 million in 2023, then increased by 21.43% to $43.3 million in 2024, then tumbled by 130.8% to -$13.3 million in 2025.
- Its Other Gross PP&E Adjustments was -$13.3 million in Q3 2025, compared to -$14.8 million in Q2 2025 and -$16.3 million in Q1 2025.